期刊文献+

跟骨定量超声对绝经后女性2型糖尿病患者骨折风险评估的意义 被引量:12

Evaluation of fracture risk in postmenopausal women with type 2 diabetes mellitus based on calcaneus quantitative ultrasound
原文传递
导出
摘要 目的探讨定量超声对绝经后女性T2DM患者骨折风险的评估价值。方法选取2012~2017年于我院内分泌科就诊的绝经后女性T2DM患者492例(T2DM组),同期于我院健康体检的绝经后女性398名(NC组)。运用超声骨密度仪(QUS)和双能X射线骨密度仪(DXA)分别测量两组骨强度指数(SI)、骨密度(BMD)及骨代谢标志物。采用骨折风险预测工具(FRAX)计算10年任何重要部位骨质疏松性骨折概率(PMOF)、髋部骨折概率(PHF),比较两组SI、BMD、PMOF、PHF及骨代谢标志物。采用多元回归分析PMOF、PHF的影响因素。结果 (1)两组BMD和骨质疏松症(OP)患病率比较,差异无统计学意义(P>0.05)。(2)与NC组相比,T2DM组SI、25羟维生素D[25(OH)D]、骨钙素(BGP)、血清I型原胶原N-端前肽(PINP)、血清1型胶原交联β-C-末端肽(β-CTX)降低(P<0.05或P<0.01),HbA1c、PMOF、PHF和甲状旁腺素(PTH)升高(P<0.05或P<0.01);(3)NC组DXA和QUS两种方法T-值(≤-2.5)发生率比较,差异无统计学意义(P>0.05);T2DM组QUS法T-值(≤-2.5)发生率低于DXA法(P<0.05);(4)T2DM组QUS法较DXA法针对FRAX评分的敏感性和特异性均更强(37%vs25%,98%vs 90%);(5)多元回归分析结果显示,SI及PINP、β-CTX是PMOF的影响因素,SI和β-CTX是PHF的影响因素。结论跟骨定量超声和骨代谢标志物可能是评估绝经后女性T2DM患者骨折风险有效手段。 Objective To evaluate the fracture risk in postmenopausal women with type 2diabetes mellitus (T2DM)based on calcaneus quantitative ultrasound (QUS). Methods Postmenopausal women with T2DM from Department of Endocrinology,The Anhui Provincial Hospital Affiliated to Anhui Medical University from 2012to 2017were enrolled in this study and assigned into T2DM group (n =492). And healthy postmenopausal women from physical examination center were assigned into NC group (n =398).Bone strength index (SI)and bone mineral density (BMD)were measured by QUS and dual energy X ray absorptiometry (DXA)respectively in the two groups.Bone turnover markers were tested. Fracture Risk Assessment Tool (FRAX)was used to predict the risk of major osteoporotic fracture (PMOF)and the probability of hip fracture (PHF).SI,BMD,PMOF,PHF and bone turnover markers were compared between the two groups. Results (1)There was no statistically significant difference in BMD and osteoporosis prevalence between T2DM group and NC group (all P >0.05). (2)The SI was lower (P<0.05), PMOF and PHF were higher (P<0.05orP<0.01)in T2DM group than in NC group.The 25-OH-vitamin D [ 25 (OH)D ], osteocalcin (BGP), procollagen type 1aminoterminal propeptide (PINP), and cross-linked C-terminal telopeptide of type I collagen (β-CTX)were decreased,while PTH was increased in T2DM group than in NC group (P<0.05orP<0.01). (3)There was no statistically significant difference in measuring of bone mass between DXA and QUS in NC group (P >0.05). Whereas,the odds of QUS stiffness T score (≤-2.5)was lower than that of BMD (FN)measured by DXA in T2DM group (P<0.05). (4)The sensitivity and specificity regarding to FRAX scores were higher in QUS than in DXA in T2DM group (37% vs 25%,98% vs 90%). (5)In T2DM group,multivariate regression analysis revealed that SI,β-CTX and PINP were negatively correlated with PMOF (β =-0.251,-0.132,-0.235,P<0.05orP<0.01); and SI,β-CTX was negatively correlated with PHF (β =-0.163,-0.132,P<0.05). Conclusion Calcaneus QUS and bone turnover markers may be used as predictors of osteoporotic fracture risk in postmenopausal women with T2DM.
作者 宁珂 陈超 邢学农 叶山东 NING Ke;CHEN Chao;XING Xuenong(Department of Endocrinology,The Anhui Provincial Hospital Affiliated to Anhui Medical University,Hefei 230001,China)
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2018年第12期1004-1008,共5页 Chinese Journal of Diabetes
基金 安徽省卫生厅医学科研课题项目(13zc003)
关键词 糖尿病 2型 绝经后女性 骨折风险 定量超声 骨强度指数 骨代谢标志物 Diabetes mellitus,type 2 Postmenopausal women Fracture risk Quantitative ultrasound Bone strength index Bone turnover markers
  • 相关文献

参考文献2

二级参考文献35

  • 1郭颖,丁鹤林,傅祖植.女性2型糖尿病患者血糖控制与骨密度关系的分析[J].中山大学学报(医学科学版),2007,28(2):184-187. 被引量:8
  • 2黄萍,刘丰,王衍慧,罗时敏.老年2型糖尿病患者糖化血红蛋白及尿白蛋白与骨密度变化的分析[J].中国骨质疏松杂志,2007,13(4):267-268. 被引量:10
  • 3Yang WY,Lu JM,Weng JP. Prevalence of Diabetes among Men and Women in China[J].{H}New England Journal of Medicine,2010.1090-1101.
  • 4Michael F,Holiek N. Vitamin D deficiency[J].{H}New England Journal of Medicine,2007.266-281.
  • 5Taverna MJ,Selam JL,Slama G. Association between a protein polymorphism in the start codon of the vitamin Dreceptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes[J].J Cli Endo Meta,2005.4803-4808.
  • 6Lee S,Clark SA,Gill RK. 1,25-2Dihydroxyvitamin D(3)and pancreatic beta-cell function-vitamin-D receptors,gene expression,and insulin-secretion[J].{H}ENDOCRINOLOGY,1994.1602-1610.
  • 7Ohara I,Tanimoto M,Gohda T. Effect of Comination Therapy with Angiotensin Receptor Blocker and 1,25-Dihydroxyvitamin D3 in Type 2 Diabetic Nephropathy in KK-Ay/Ta Mice[J].{H}NEPHRON EXPERIMENTAL NEPHROLOGY,2011.e124-e132.
  • 8Shab-Bidar S,Neyestani TR,Djazayery A. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2diabetes[J].{H}Diabetes/Metabolism Research and Reviews,2012.424-430.
  • 9Autier P,Gandini S. Vitamin D supplementation and total motality:A meta-analysis of randomized controlled trials[J].{H}Archives of Internal Medicine,2007.1730-1737.
  • 10Dawson-Hughes B,Heaney RP,Holick MF. Estimates of optimal vitamin D status[J].{H}Osteoporosis International,2005.713-716.

共引文献21

同被引文献115

引证文献12

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部